Automated immunoassays to maximize productivity in bioprocess development
High productivity in bioprocess development demands efficient bioanalytical procedures to measure, for example, product titer and process impurities, but commonly used methods, such as enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography, can create bottlenecks in critical workflows.
Gyros’ open nanoliter-scale immunoassay platform improves productivity in bioanalytical workflows by providing rapid assay development time, automation, high throughput, and a broad dynamic range that minimizes dilutions and repeats.
Gyrolab™ systems (Gyrolab™ xP and Gyrolab xPlore™) have been implemented in many bioprocess development labs and are routinely used to determine:  
IgG product titer during clone selection and cell culture development
Host Cell Proteins and Leached Protein A impurities during downstream purification processes